Plain-English translation of NCT07601763 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer procedure called pulsed field ablation to treat atrial fibrillation—a condition where your heart beats irregularly. The new treatment uses electrical pulses to fix the problem areas in your heart, and researchers believe it may work better and cause less damage to nearby tissues compared to the standard electrical treatment currently used.
Atrial fibrillation affects millions of people worldwide and increases your risk of stroke and heart failure. While electrical ablation procedures help many patients, this trial exists to see whether the new treatment is safer and more effective, especially because it may better protect important structures around your heart like the esophagus and nerves.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the new pulsed field ablation procedure or the standard electrical ablation procedure. Both are catheter-based procedures performed by a cardiologist. The study will track your heart rhythm and symptoms over time to compare how well each treatment works and how safe each is for you.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China